Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04964960
Title Pembro+Chemo in Brain Mets
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors John L. Villano, MD, PhD
Indications

lung non-small cell carcinoma

Therapies

Paclitaxel + Pembrolizumab

Nab-paclitaxel + Pembrolizumab

Pembrolizumab + Pemetrexed Disodium

Carboplatin + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Kentucky, Markey Cancer Center Recruiting Lexington Kentucky 40536 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field